| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $363.3M | +3.4% |
| R&D Expense | $705.8M | +42.0% |
| SG&A Expense | $278.1M | +26.4% |
| Operating Income | -$648.9M | -70.0% |
| Pre-tax Income | -$701.7M | -54.9% |
| Income Tax | $5.7M | +445.6% |
| Net Income | -$707.4M | -55.8% |
| EPS (Basic) | -$10.12 | -51.0% |
| EPS (Diluted) | -$10.12 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $132.9M | -56.8% |
| Accounts Receivable | $40.4M | +42.3% |
| Inventory | $26.8M | +64.9% |
| Current Assets | $883.9M | +3.2% |
| Total Assets | $1.55B | +1.5% |
| Current Liabilities | $261.2M | +44.0% |
| Total Liabilities | $1.19B | +98.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$380.5M | -12.3% |
| Capital Expenditures | $116.1M | +58.9% |
| Investing Cash Flow | -$291.7M | -49.3% |
| Financing Cash Flow | $501.2M | +322.8% |
| Free Cash Flow | -$496.6M | -20.6% |
| -51.0% |
| Stockholders' Equity |
| $352.5M |
| -61.8% |